2022 - Research.com Best Scientist Award
2011 - Fellow of the American Association for the Advancement of Science (AAAS)
Member of the Association of American Physicians
Robert M. Strieter focuses on Immunology, Chemokine, Cytokine, Tumor necrosis factor alpha and Pathology. His Immunology research is multidisciplinary, incorporating elements of Lung injury and Lung. The concepts of his Chemokine study are interwoven with issues in Cancer research, Angiogenesis, Neovascularization and Chemotaxis.
In general Cytokine study, his work on Interleukin 8 often relates to the realm of Synovial fluid, thereby connecting several areas of interest. His Tumor necrosis factor alpha research incorporates elements of Lipopolysaccharide, Molecular biology and Macrophage. His Pathology study combines topics from a wide range of disciplines, such as Central nervous system and Transplantation.
His primary areas of investigation include Immunology, Chemokine, Cytokine, Tumor necrosis factor alpha and Inflammation. His Immunology course of study focuses on Lung and Pathology. In his study, which falls under the umbrella issue of Pathology, Respiratory disease is strongly linked to Bronchoalveolar lavage.
His studies in Chemokine integrate themes in fields like Cancer research, Angiogenesis and Cell biology. In Cytokine, Robert M. Strieter works on issues like Molecular biology, which are connected to Peripheral blood mononuclear cell. His study looks at the relationship between Tumor necrosis factor alpha and fields such as In vivo, as well as how they intersect with chemical problems.
The scientist’s investigation covers issues in Immunology, Cancer research, Chemokine, Angiogenesis and CXC chemokine receptors. The study incorporates disciplines such as Cancer, Internal medicine, Lung cancer, Interleukin 8 and Chemokine receptor in addition to Cancer research. His biological study spans a wide range of topics, including Cytokine and CCL19.
Robert M. Strieter combines subjects such as Tumor microenvironment and Immunotherapy with his study of Chemokine. His research investigates the connection between Angiogenesis and topics such as Metastasis that intersect with issues in Renal cell carcinoma. His CXC chemokine receptors research integrates issues from Cell biology, Lung injury, Pancreatic cancer and Pathology.
Robert M. Strieter mainly investigates Cancer research, Angiogenesis, Immunology, CXC chemokine receptors and Neovascularization. His Cancer research research is multidisciplinary, incorporating elements of Chemokine and Signal transduction. His Chemokine study is related to the wider topic of Immune system.
His Immunology study incorporates themes from Interleukin 12 and Transplantation. Endothelial stem cell and Chemokine receptor is closely connected to Interleukin 8 in his research, which is encompassed under the umbrella topic of CXC chemokine receptors. Robert M. Strieter focuses mostly in the field of Neovascularization, narrowing it down to matters related to Pathology and, in some cases, Gastroenterology, Lung, Idiopathic pulmonary fibrosis and Lung injury.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Interleukin-8 as a macrophage-derived mediator of angiogenesis.
Alisa E. Koch;Peter J. Polverini;Steven L. Kunkel;Lisa A. Harlow.
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Robert M. Strieter;Peter J. Polverini;Steven L. Kunkel;Douglas A. Arenberg.
Journal of Biological Chemistry (1995)
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Roderick J. Phillips;Marie D. Burdick;Kurt Hong;Marin A. Lutz.
Journal of Clinical Investigation (2004)
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
Torben L. Sørensen;Marie Tani;Jakob Jensen;Virginia Pierce.
Journal of Clinical Investigation (1999)
Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.
L M Colletti;D G Remick;G D Burtch;S L Kunkel.
Journal of Clinical Investigation (1990)
CXC Chemokines in Angiogenesis
John A. Belperio;Michael P. Keane;Douglas A. Arenberg;Christina L. Addison.
Journal of Leukocyte Biology (2000)
Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta.
RM Strieter;SL Kunkel;HJ Showell;DG Remick.
Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44.
Charlotte M. McKee;Margaret B. Penno;Mary Cowman;Marie D. Burdick.
Journal of Clinical Investigation (1996)
Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups
S. C. Donnelly;C. Haslett;Robert M. Strieter;Steven L. Kunkel.
The Lancet (1993)
Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo
Tariq Sethi;Robert C. Rintoul;Sarah M. Moore;Alison C. MacKinnon.
Nature Medicine (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: